Forging partnerships between science and policy: A high-level Antimicrobial Resistance (AMR) event
26 April 2024 from 15:30 to 19:00 CEST
No registration required
Full scientific programme here
ESCMID is pleased to host this high-level ESCMID Global (formerly known as ECCMID) affiliated event in partnership with the Global Leaders Group on Antimicrobial Resistance (GLG). We welcome you all to join us on 26 April 2024 from 15:30 to 19:00 CEST, Fira Gran Via (North Access), Barcelona, Spain. The event will also be live-streamed on the ESCMID Facebook and YouTube channels.
This high-level event is intended to position research, science and implementation into the political agenda of AMR and address the pressing needs of AMR across all sectors. It is a critical time for this discussion and alignment leading up to the United Nations General Assembly High-level Meeting on AMR to be held in September 2024 in New York, USA.
Antimicrobial resistance (AMR) causes 1.3 million deaths and contributes to 5 million deaths every year. By 2030, AMR could force 24 million people into extreme poverty. The drivers of AMR are multifaceted. New and affordable diagnostic testing, disease-prediction tools, vaccines, and non-antimicrobial alternatives do not exist. Research will be needed to help identify the best possible interventions, solutions and approaches in a multi-disciplinary and multi-sectoral manner. Financial and political commitment, as well as scientific interest, through engagement of governments, private sector, and civil society are crucial. The Global Leaders Group on Antimicrobial Resistance (GLG) is comprised of world leaders and experts from across sectors, committed to accelerating political action on AMR based on a One Health approach.
It is a critical time for this discussion and alignment leading up to the United Nations General Assembly High-level Meeting on AMR to be held in September 2024 in New York, USA. Antimicrobial resistance (AMR) causes 1.3 million deaths and contributes to 5 million deaths every year. By 2030, AMR could force 24 million people into extreme poverty. The drivers of AMR are multifaceted. New and affordable diagnostic testing, disease-prediction tools, vaccines, and non-antimicrobial alternatives do not exist. Research will be needed to help identify the best possible interventions, solutions and approaches in a multi-disciplinary and multi-sectoral manner. Financial and political commitment, as well as scientific interest, through engagement of governments, private sector, and civil society are crucial. The Global Leaders Group on Antimicrobial Resistance (GLG) is comprised of world leaders and experts from across sectors, committed to accelerating political action on AMR based on a One Health approach.
The ESCMID-GLG high-level event will be preceded by an ESCMID organised "think tank" symposium on the importance of diagnostics in AMR, from 14:00 - 15:00 CEST.
Media Contact
Tony Kirby
Tony Kirby PR
Official Press Agent of ESCMID Global (formerly ECCMID)
tony.kirby@tonykirby.com
+447834385827
Source: https://www.escmid.org/
"Reproduced with permission - "ESCMID - European Society of Clinical Microbiology and Infectious Diseases"
ESCMID - European Society of Clinical Microbiology and Infectious Diseases
For more HIV and AIDS News visit...
Positively Positive - Living with HIV/AIDS:
HIV/AIDS News
|
